Medically reviewed by Doru Paul, MD Key Takeaways Immunohistochemistry (IHC) is used to find specific molecules on cells with ...

Ultivue today unveiled the expanded capabilities of its proprietary InSituPlex® DNA-barcoding and staining technology through comprehensive visualization of a whole slide 16-marker multiplex assay in ...

Are all biopsies created equal? comparison of extended sextant prostate biopsies performed with and without MRI-TRUS fusion biopsy system. Performance of a clinically validated urine exosome gene ...

The first study using IHC was published in the 1940s when antigens of bacterial species Streptococcus pneumonia were discovered in the tissues. Since then, a wealth of developments and several ...

There is an increasing need to evaluate and understand unique phenotypes and mechanisms of action within the tissue tumor microenvironment. Conventional assays such as chromogenic immunohistochemistry ...

Immune phenotype profiling based on anatomic origin of melanoma and impact on clinical outcomes of immune checkpoint inhibitor treatment. Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: ...

Immunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases. Immunophenotyping is a lab test doctors use to identify and ...

New AI-driven tool converts common histology images into detailed, multi-layered cancer markers, promising faster, more accurate diagnostics and improved patient outcomes. Study: Accelerating ...

FRANKFURT, Germany--(BUSINESS WIRE)--NeraCare, a leading developer of laboratory tests for personalized survival prediction of melanoma patients, today announced publication of an abstract describing ...